XML 25 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements Of Changes In Shareholders' Equity - USD ($)
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning Balance (in shares) at Dec. 31, 2012   7,622,750    
Beginning Balance at Dec. 31, 2012 $ 233,815,000 $ 49,667,000 $ 181,151,000 $ 2,997,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 22,783,000   22,783,000  
Other comprehensive loss, net of tax (15,344,000)     (15,344,000)
Stock-based compensation expense 596,000 $ 596,000    
Exercise of stock options and issuance of restricted stock, net of repurchase for tax withholdings and tax benefit (in shares)   25,308    
Exercise of stock options and issuance of restricted stock, net of repurchase for tax withholdings and tax benefit 300,000 $ 300,000    
Common stock repurchased (in shares)   (68,145)    
Common stock repurchased (2,780,000) $ (2,780,000)    
Cash dividends declared ( $1.08, $1.11 and $1.20 per share in 2013, 2014, and 2015, respectively) (8,274,000)   (8,274,000)  
Equity issuance costs 0      
Ending Balance (in shares) at Dec. 31, 2013   7,579,913    
Ending Balance at Dec. 31, 2013 231,096,000 $ 47,783,000 195,660,000 (12,347,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 24,570,000   24,570,000  
Other comprehensive loss, net of tax 3,922,000     3,922,000
Stock-based compensation expense 599,000 $ 599,000    
Exercise of stock options and issuance of restricted stock, net of repurchase for tax withholdings and tax benefit (in shares)   27,664    
Exercise of stock options and issuance of restricted stock, net of repurchase for tax withholdings and tax benefit 328,000 $ 328,000    
Common stock repurchased (in shares)   (181,355)    
Common stock repurchased (7,155,000) $ (7,155,000)    
Cash dividends declared ( $1.08, $1.11 and $1.20 per share in 2013, 2014, and 2015, respectively) (8,251,000)   (8,251,000)  
Equity issuance costs 0      
Ending Balance (in shares) at Dec. 31, 2014   7,426,222    
Ending Balance at Dec. 31, 2014 245,109,000 $ 41,555,000 211,979,000 (8,425,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 20,952,000   20,952,000  
Other comprehensive loss, net of tax (3,797,000)     (3,797,000)
Stock-based compensation expense 836,000 $ 836,000    
Exercise of stock options and issuance of restricted stock, net of repurchase for tax withholdings and tax benefit (in shares)   44,494    
Exercise of stock options and issuance of restricted stock, net of repurchase for tax withholdings and tax benefit 753,000 $ 753,000    
Cash dividends declared ( $1.08, $1.11 and $1.20 per share in 2013, 2014, and 2015, respectively) (10,602,000)   (10,602,000)  
Equity issuance costs (612,000) $ (612,000)    
SBM acquisition common stock issuance (in shares)   2,749,762    
SBM acquisition common stock issuance 108,561,000 $ 108,561,000    
SBM acquisition non-qualified stock option awards 1,990,000 $ 1,990,000    
Ending Balance (in shares) at Dec. 31, 2015   10,220,478.000    
Ending Balance at Dec. 31, 2015 $ 363,190,000 $ 153,083,000 $ 222,329,000 $ (12,222,000)